Showing 141 - 160 results of 13,754 for search '(( significant side release ) OR ( significantly ((restored decrease) OR (reported decrease)) ))', query time: 0.99s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149

    Study area. by Caleb B. Fogel (12858982)

    Published 2022
    Subjects:
  10. 150
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157

    Significant change in self-reported behaviour between Pre-Test (T1) to Follow-Up (T3). by Michelle McNab (6984125)

    Published 2019
    “…Significant decrease in the number of sweets consumed per day was identified. c) Instances of tobacco use reported at T1 and T3. …”
  18. 158

    Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report by Nashimoto S. (17866511)

    Published 2024
    “…Mycophenolate mofetil (MMF), an inactive prodrug of mycophenolic acid (MPA), is an immunosuppressive drug used widely in the treatment of lupus nephritis. In this case report, the area under the blood concentration time curve (AUC) of MPA was significantly decreased by the concomitant use of sacubitril/valsartan. …”
  19. 159
  20. 160

    <i>Mycobacterium tuberculosis</i> thymidylate synthase (ThyX) is a target for plumbagin, a natural product with antimycobacterial activity by Apurba Sarkar (8399571)

    Published 2020
    “…We also show that the intracellular [dTTP]/[dATP] ratio in <i>Mycobacterium smegmatis</i> (Msm) cells decrease upon treatment with plumbagin, and this, in turn, leads to cell death. …”